Suppr超能文献

C反应蛋白/预后营养指数比值在接受放疗的Ⅲ期和Ⅳ期喉癌患者中的预后价值

The Prognostic Value of the C-reactive Protein/Prognostic Nutritional Index Ratio in Stage III and IV Laryngeal Cancer Patients Treated with Radiotherapy.

作者信息

Fu Jie, Yang Xiaojing

机构信息

Radiation Oncology, Shanghai Jiao Tong University Affliated Sixth People's Hospital, Shanghai, CHN.

出版信息

Cureus. 2019 May 12;11(5):e4648. doi: 10.7759/cureus.4648.

Abstract

Objective Patients with advanced laryngeal cancer have a poor prognosis. The purpose of this work was to analyze the connection between clinical factors and survival and to try to identify survival prognostic factors. Methods Sixty-one laryngeal cancer patients received radiotherapy. All of their clinicopathologic material was gathered from a retrospective review of the medical records and subjected to further analysis. We examined the prognostic significance of the C-reactive protein (CRP)/prognostic nutritional index (PNI) ratio. Results We assessed the CRP and PNI levels before radiotherapy. An analysis of overall survival (OS) of patients with high CRP/PNI was markedly shorter than for those patients with a low CRP/PNI (P=0.010). Multivariable analysis showed that a high CRP/PNI ratio was a disadvantageous independent prognostic marker. Conclusions The data show that CRP/PNI may be used as a prognostic indicator for laryngeal cancer patients treated with radiotherapy.

摘要

目的 晚期喉癌患者预后较差。本研究旨在分析临床因素与生存率之间的关联,并尝试确定生存预后因素。方法 61例喉癌患者接受了放射治疗。所有患者的临床病理资料均通过回顾病历进行收集,并进行进一步分析。我们检测了C反应蛋白(CRP)/预后营养指数(PNI)比值的预后意义。结果 我们在放疗前评估了CRP和PNI水平。高CRP/PNI患者的总生存期(OS)分析显示明显短于低CRP/PNI患者(P = 0.010)。多变量分析表明,高CRP/PNI比值是一个不利的独立预后标志物。结论 数据表明,CRP/PNI可作为接受放射治疗的喉癌患者的预后指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e8a/6624156/1642e90a7933/cureus-0011-00000004648-i01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验